Literature DB >> 12566080

Impaired receptor-mediated endocytosis by the asialoglycoprotein receptor in ethanol-fed mice: implications for studying the role of this receptor in alcoholic apoptosis.

Shana R Dalton1, Robert L Wiegert, Cheryl R Baldwin, Karen M Kassel, Carol A Casey.   

Abstract

During receptor-mediated endocytosis (RME), extracellular molecules are internalized after being recognized and bound to specific cell surface receptors. In previous studies of the asialoglycoprotein receptor (ASGPR) in rats, we showed that ethanol impairs RME at multiple ASGPR sites. Ethanol administration has been shown to increase apoptosis, and we demonstrated increased sensitization to apoptotic induction in hepatocytes from ethanol-fed rats. Although a physiological role for the ASGPR has not been identified, investigators have shown its involvement in the uptake/clearance of apoptotic cells in vitro. This suggests a potential role for the ASGPR in the removal of apoptotic cells, and the recent availability of an ASGPR-deficient mouse strain provides an excellent opportunity to examine the role of the ASGPR during ethanol impairment. In this study, we examined ethanol-impaired RME in mice and began the characterization of ASGPR-deficient mice for use in ethanol studies. Similar to our findings with rats, ligand binding, internalization, and degradation were decreased 45-50% in hepatocytes from ethanol-fed wild-type mice. In ASGPR-deficient mice, these parameters did not vary among the chow-fed, pair-fed control, or ethanol groups and were negligible compared with those of wild-type mice. TUNEL analysis of liver sections showed an ethanol-induced increase in apoptotic bodies in all mouse strains with a significant difference in the receptor-deficient mice. Further, the livers of ASGPR-deficient mice had three times more apoptotic bodies, in all feeding groups, compared with wild-type mice. These results support the use of the ASGPR-deficient mouse model for studying ethanol-induced liver injury, specifically ethanol-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12566080     DOI: 10.1016/s0006-2952(02)01555-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Ethanol withdrawal mitigates fatty liver by normalizing lipid catabolism.

Authors:  Paul G Thomes; Karuna Rasineni; Li Yang; Terrence M Donohue; Jacy L Kubik; Mark A McNiven; Carol A Casey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-02-04       Impact factor: 4.052

2.  Enhanced colorectal cancer metastases in the alcohol-injured liver.

Authors:  Ashley M Mohr; John J Gould; Jacy L Kubik; Geoffrey A Talmon; Carol A Casey; Peter Thomas; Dean J Tuma; Benita L McVicker
Journal:  Clin Exp Metastasis       Date:  2017-02-06       Impact factor: 5.150

Review 3.  Impact of asialoglycoprotein receptor deficiency on the development of liver injury.

Authors:  Serene M L Lee; Carol A Casey; Benita L McVicker
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

4.  Ethanol inhibits L1 cell adhesion molecule activation of mitogen-activated protein kinases.

Authors:  Ningfeng Tang; Min He; Mary Ann O'Riordan; Chloe Farkas; Kevin Buck; Vance Lemmon; Cynthia F Bearer
Journal:  J Neurochem       Date:  2006-03       Impact factor: 5.372

Review 5.  APC licensing and CD4+T cell help in liver-stage malaria.

Authors:  Ian N Crispe
Journal:  Front Microbiol       Date:  2014-11-11       Impact factor: 5.640

Review 6.  Clearance of Apoptotic Cells by Tissue Epithelia: A Putative Role for Hepatocytes in Liver Efferocytosis.

Authors:  Scott P Davies; Gary M Reynolds; Zania Stamataki
Journal:  Front Immunol       Date:  2018-01-25       Impact factor: 7.561

7.  Downregulation of the small GTPase SAR1A: a key event underlying alcohol-induced Golgi fragmentation in hepatocytes.

Authors:  Armen Petrosyan; Pi-Wan Cheng; Dahn L Clemens; Carol A Casey
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

8.  Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression.

Authors:  Jennifer L S Willoughby; Amy Chan; Alfica Sehgal; James S Butler; Jayaprakash K Nair; Tim Racie; Svetlana Shulga-Morskaya; Tuyen Nguyen; Kun Qian; Kristina Yucius; Klaus Charisse; Theo J C van Berkel; Muthiah Manoharan; Kallanthottathil G Rajeev; Martin A Maier; Vasant Jadhav; Tracy S Zimmermann
Journal:  Mol Ther       Date:  2017-09-07       Impact factor: 11.454

9.  Susceptibility of Asialoglycoprotein Receptor-Deficient Mice to Lps/Galactosamine Liver Injury and Protection by Betaine Administration.

Authors:  Karuna Rasineni; Serene M L Lee; Benita L McVicker; Natalia A Osna; Carol A Casey; Kusum K Kharbanda
Journal:  Biology (Basel)       Date:  2020-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.